Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021)

Acro Biomedical (ACBM) recorded quarterly Share-based Compensation of $3.9 million in Q4 2021, up 34.59% quarter-over-quarter from $2.9 million in Q3 2021.

Acro Biomedical (ACBM) Share-based Compensation (2018 - 2021) Analysis & Trends

Acro Biomedical's Share-based Compensation history runs 3 years deep, the most recent figure standing at $3.9 million for Q4 2021.

  • In Q4 2021, Share-based Compensation changed N/A year-over-year to $3.9 million; the TTM figure through Dec 2021 stood at $7.0 million (changed N/A YoY), while the FY2021 annual figure was $7.7 million, changed N/A from the prior year.
  • Share-based Compensation was $3.9 million for Q4 2021 at Acro Biomedical, up from $2.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.9 million in Q4 2021 to a low of $148395.0 in Q1 2019.
  • Historically, Share-based Compensation has averaged $1.2 million across 3 years, with a median of $150044.5 in 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - -
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - -
3 Berto Acquisition 311.56 Mn 311.56 Mn - -
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -
5 Centurion Acquisition 310.21 Mn 310.21 Mn - -
6 WEN Acquisition 309.15 Mn 309.15 Mn - -
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - -
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - -
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - -
10 Acro Biomedical - - - -

Historic Data

Download Data
DateValue
Dec 31, 2021 3.93 Mn
Dec 31, 2021 3.93 Mn
Sep 30, 2021 2.92 Mn
Sep 30, 2021 2.92 Mn
Sep 30, 2019 148,395.00
Sep 30, 2019 148,395.00
Jun 30, 2019 148,395.00
Jun 30, 2019 148,395.00
Mar 31, 2019 148,395.00
Mar 31, 2019 148,395.00
Dec 31, 2018 151,694.00
Dec 31, 2018 151,694.00